Core Insights - Dingdang Health's subsidiary, Dingdang Kuaiyao, has launched the innovative insomnia treatment drug, Leberesin (brand name: Daweike), which can be ordered online and delivered to patients' homes within 28 minutes, significantly improving accessibility and convenience for insomnia patients [1] - Leberesin is a non-psychoactive medication that aims to help long-term insomnia sufferers return to a natural sleep rhythm [1] - The drug has been approved in 26 countries and regions globally, with over 6 million users, and has recently received approval for domestic market entry [1] Company Strategy - Dingdang Health is focusing on the insomnia market and leveraging its digital capabilities through Dingdang Smart Pharmacy, which offers real-time online health consultation services, 24-hour professional medication delivery, AI medication reminders, and sleep health management guidance [1] - The company is committed to the "Innovative Drugs · Life Ark" initiative starting in 2025, having developed a portfolio of innovative drug products covering various disease areas, including insomnia, neurological disorders, endocrine metabolism, tumors, cardiovascular diseases, and inflammatory bowel disease [1]

Core Insights - Dingtang Health reported a revenue of 4.669 billion yuan for the fiscal year 2024, with a record gross profit of 1.538 billion yuan and a gross margin of 32.9%, reflecting a year-on-year increase of 1.8 percentage points [1] - The company successfully narrowed its adjusted losses by 32% through supply chain optimization, digital operations, and cost control, demonstrating strategic resilience amid industry changes [1][2] Strategic Layout - In 2024, Dingtang Health aims to build an integrated ecosystem focusing on "medical, testing, pharmaceuticals, and insurance," while continuously enhancing AI technology to improve efficiency across the entire supply chain [3] - The deepening of digital operations has led to improved inventory accuracy during peak seasons, reduced labor costs, and enhanced operational decision-making capabilities [3] - The company has successfully implemented a "medication online ordering and delivery + online medical insurance payment" model in key cities like Beijing, Shanghai, Shenzhen, and Foshan, which is expected to activate existing users and generate new business opportunities [3] Ecosystem Development - Dingtang Health is strengthening ecological cooperation and industry barriers by collaborating with over 7,000 well-known pharmaceutical companies and distributors to enhance its pharmaceutical health supply chain [4] - The company provides convenient cold chain delivery services for diabetes patients and those with special medication needs in Shenzhen and Beijing, maintaining an integrated online and offline service model [4] Future Outlook - Company representatives stated that the next steps involve optimizing structure, focusing on growth in core cities, and enhancing the warehousing and distribution system to offer users a more professional, convenient, diverse, and intelligent service experience [5] - Dingtang Health aims to become the "smart health service gateway" and "intelligent professional pharmaceutical health service provider" in the AI+ era [5]